Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Community
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • Vax-Unvax: Let The Science Speak Home › Citations

    Chapter 11

    This is a listing of all citations in this chapter.

    91

    Ousseny Zerbo, et al., “Association Between Influenza Infection and Vaccination During Pregnancy and Risk of Autism Spectrum Disorder,” JAMA Pediatrics 171, no. 1 (2017): e163609, doi:10.1001/jamapediatrics.2016.3609.

    92

    Cristopher S. Price et al., “Prenatal and Infant Exposure to Thimerosal from Vaccines and Immunoglobulins and Risk of Autism,” Pediatrics 126, no. 4 (2010): 656–664, doi:10.1542/peds.2010-0309.

    93

    Alberto Donzelli, “Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring,” International Journal of Environmental Research and Public Health 16, no. 22 (2019): 4347, doi:10.3390/ijerph16224347.

    94

    Lisa M. Christian et al., “Inflammatory Responses to Trivalent Influenza Virus Vaccine among Pregnant Women,” Vaccine 29, no. 48, (2011): 8982–8987, doi:10.1016/j.vaccine.2011.09.039.

    95

    J.B. Layton et al., “Prenatal Tdap Immunization and Risk of Maternal and Newborn Adverse Events,” Vaccine 35, no. 33 (2017): 4072–4078, doi:10.1016/j.vaccine.2017.06.071.

    96

    J.B. Layton et al., “Prenatal Tdap Immunization and Risk of Maternal and Newborn Adverse Events,” Vaccine 35, no. 33 (2017): 4072–4078, doi:10.1016/j.vaccine.2017.06.071.

    97

    Malini De Silva et al., “Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy,” The New England Journal of Medicine 387, no. 2 (2022): 187–189, doi:10.1056/NEJMc2205276.

    98

    Elyse O. Kharbanda et al., “Evaluation of the Association of Maternal Pertussis Vaccination with Obstetric Events and Birth Outcomes,” JAMA 312, no. 18 (2014): 1897–1904, doi:10.1001/jama.2014.14825.

    99

    J.B. Layton et al., “Prenatal Tdap Immunization and Risk of Maternal and Newborn Adverse Events,” Vaccine 35, no. 33 (2017): 4072–4078, doi:10.1016/j.vaccine.2017.06.071.

    100

    Pedro Moro et al., “Enhanced Surveillance of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccines in Pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2011-2015,” Vaccine 34, no. 20 (2016): 2349–2353, doi:10.1016/j.vaccine.2016.03.049.

    101

    “VAERS Data,” Vaccine Adverse Event Reporting System (VAERS), updated April 7, 2023.

    102

    Aharon Dick et al., “Safety of Third SARS-CoV-2 Vaccine (Booster Dose) During Pregnancy,” American Journal of Obstetrics & Gynecology MFM 4, no.4 (2022): 100637, doi:10.1016/j.ajogmf.2022.100637.

    103

    Aharon Dick et al., “Safety of Third SARS-CoV-2 Vaccine (Booster Dose) During Pregnancy,” American Journal of Obstetrics & Gynecology MFM 4, no.4 (2022): 100637, doi:10.1016/j.ajogmf.2022.100637.

    104

    “VAERS Data,” Vaccine Adverse Event Reporting System (VAERS), updated April 7, 2023.

    105

    Itai Gat et al., “Covid-19 Vaccination BNT162b2 Temporarily Impairs Semen Concentration and Total Motile Count among Semen Donors,” Andrology 10, no. 6 (2022): 1016–1022, doi:10.1111/andr.13209.

    106

    Itai Gat et al., “Covid-19 Vaccination BNT162b2 Temporarily Impairs Semen Concentration and Total Motile Count among Semen Donors,” Andrology 10, no. 6 (2022): 1016–1022, doi:10.1111/andr.13209.

    107

    Malini De Silva et al., “Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy,” The New England Journal of Medicine 387, no. 2 (2022): 187–189, doi:10.1056/NEJMc2205276.